Back
Arcelik AS Vs. Viking Therapeutics Industry Stock Comparison
Buy
62
ACKAY
Arcelik AS
Last Price:
26.75
Seasonality Move:
-2.39%
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Buy
62
Arcelik AS (ACKAY)
is a Buy
Is Arcelik AS a Buy, Sell or Hold?
- The current Arcelik AS [ACKAY] share price is $26.75. The Score for ACKAY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ACKAY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACKAY Stock Price Chart
What is Arcelik AS's stock price today?
-
The Arcelik AS share price today is $26.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACKAY is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACKAY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 77.61 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.74 - 24.9) | Buy |
| Bollinger Bands (100): | (21.62 - 25.16) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.32 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | 2857375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.57 - 61.31) | Sell |
| Bollinger Bands (100): | (46.52 - 79.44) | Sell |
ACKAY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.67 | Buy |
| 20-day SMA: | 23.92 | Buy |
| 50-day SMA: | 23.62 | Buy |
| 200-day SMA: | 23.85 | Buy |
| 8-day EMA: | 25.18 | Buy |
| 20-day EMA: | 24.28 | Buy |
| 50-day EMA: | 23.79 | Buy |
| 200-day EMA: | 23.92 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.48 | Buy |
| 20-day SMA: | 54.1 | Sell |
| 50-day SMA: | 63.93 | Sell |
| 200-day SMA: | 39 | Buy |
| 8-day EMA: | 50.61 | Buy |
| 20-day EMA: | 54.34 | Sell |
| 50-day EMA: | 59.63 | Sell |
| 200-day EMA: | 45.62 | Buy |
Arcelik AS Earnings Growth & ACKAY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Arcelik AS Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||